Press release
Cancer Diagnostics Market to Reach USD 156.97 Billion by 2029, Driven by Advancements in Biomarkers and Imaging Technologies
Cancer Daignostics Market Size
The global cancer diagnostics market, valued at USD 106.24 billion in 2024, is projected to grow to USD 156.97 billion by 2029, registering a compound annual growth rate (CAGR) of 8.12%. The market's growth is fueled by the rising prevalence of cancer, advancements in diagnostic technologies such as biomarkers and point-of-care diagnostics, and increasing accessibility to early screening tools. Despite challenges posed by high diagnostic costs and regulatory frameworks, the market is poised for robust growth, supported by innovations and global awareness initiatives.
Report Overview: https://www.mordorintelligence.com/industry-reports/cancer-diagnostic-market
Key Trends
1. Rising Global Cancer Prevalence
The escalating number of cancer cases worldwide is a significant driver for the diagnostics market:
According to Globocan, over 30 million people are expected to live with cancer by 2040, emphasizing the need for early and accurate diagnosis.
The geriatric population, a high-risk demographic, is increasingly utilizing cancer screening tests, boosting demand for diagnostic procedures.
2. Advancements in Diagnostic Imaging
Imaging technologies continue to dominate cancer diagnostics due to their reliability and continuous innovation:
Technologies like CT scans, MRIs, and mammograms remain the cornerstone of cancer detection.
Recent innovations, such as the NearWave Imager for breast cancer detection developed in 2022, highlight the ongoing advancements in imaging technologies.
3. Technological Innovations in Biomarkers and Point-of-Care Diagnostics
Biomarkers are revolutionizing cancer diagnostics by enabling precision medicine:
The use of liquid biopsies and genetic markers facilitates early detection and monitoring, offering non-invasive diagnostic solutions.
Point-of-care technologies are becoming more accessible, expanding diagnostic capabilities even in low-resource settings.
4. Growing Awareness and Screening Initiatives
Awareness campaigns and screening programs are driving market growth:
Initiatives like the American College of Radiology's Contrast-Enhanced Mammography Imaging Screening Trial aim to improve breast cancer detection rates and reduce false positives.
Market Segmentation
The cancer diagnostics market is segmented by Diagnostic Type, Application, and Geography:
By Diagnostic Type:
Diagnostic Imaging Tests: Includes CT scans, MRIs, mammograms, and X-rays.
Biopsy and Cytology Tests: Gold-standard methods for confirming cancer diagnosis.
Tumor Biomarkers: Enabling precision medicine and non-invasive diagnosis.
By Application:
Breast Cancer: Most widely diagnosed with advancements in mammography and imaging.
Lung Cancer: High demand for early detection technologies.
Cervical Cancer: Increasing adoption of HPV tests and Pap smears.
Other Cancers: Includes liver, pancreatic, and ovarian cancers.
By Geography:
North America: Largest market due to advanced healthcare infrastructure and high awareness.
Asia-Pacific: Fastest-growing region, driven by a rising cancer burden and healthcare investments.
Europe: Strong focus on innovation and healthcare policies supporting diagnostics.
Middle East & Africa, South America: Emerging markets with increasing awareness and diagnostic access.
Get a Customized Report Tailored to Your Requirements - https://www.mordorintelligence.com/market-analysis/diagnostic-devices
Key Players
The cancer diagnostics market features key players leveraging innovation and partnerships to maintain leadership. Major companies include Siemens Healthineers, GE Healthcare, Roche Diagnostics, Thermo Fisher Scientific, and Hologic, Inc.
Siemens Healthineers: Known for its advanced imaging solutions, including the Naeotom Alpha launched in 2021 for enhanced diagnostics.
GE Healthcare: Focuses on improving cancer detection through advanced imaging and AI solutions.
Roche Diagnostics: A leader in biomarker development and precision diagnostics.
Thermo Fisher Scientific: Innovates in genetic and liquid biopsy diagnostics.
Hologic, Inc.: Specialized in breast cancer screening technologies like advanced mammography systems.
These companies are actively investing in research and development to offer cutting-edge diagnostic tools and improve cancer care outcomes.
Conclusion
The cancer diagnostics market is set for substantial growth, driven by rising cancer prevalence, advancements in technology, and increased awareness about early detection. As imaging and biomarker technologies continue to evolve, the market is expected to play a critical role in enhancing patient outcomes and reducing cancer mortality rates. With major players focusing on innovation and expanding access to diagnostic tools globally, the cancer diagnostics market is poised to meet the growing demand for early and accurate detection in the years ahead.
Industry Related Reports
Brain Tumor Diagnostics Market: The report highlights trends in the Brain Dead Diagnosis and Treatment Market, which is segmented by Diagnostic Type (Imaging Tests, Lumbar Puncture, Biopsy, Molecular Testing, and Others), Tumor Type (Metastatic, Meningioma, Glioblastoma, Pituitary Adenoma, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more vsit this link: https://www.mordorintelligence.com/industry-reports/brain-tumor-diagnostics-market
Tissue Diagnostics Market: The Report is segmented by Product (Instruments and Reagents & Consumables), Technology (Immunohistochemistry, In-Situ Hybridization, Digital Pathology & Workflow Management, and Other Technologies), Application (Breast Cancer, Prostate Cancer, Gastric Cancer, and Other Cancers), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/global-tissue-diagnostics-market-industry
Thyroid Cancer Diagnostics Market: The Market is segmented by Disease Type (Papillary Carcinoma, Follicular Carcinoma, and Other Disease Types), Diagnostic Technique (Blood Tests, Imaging, Biopsy, and Other Diagnostic Techniques), End User (Hospital Laboratories, Cancer Diagnostic Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/thyroid-cancer-diagnostics-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Diagnostics Market to Reach USD 156.97 Billion by 2029, Driven by Advancements in Biomarkers and Imaging Technologies here
News-ID: 3756103 • Views: …
More Releases from Mordor Intelligence
Dairy Alternatives Market to Reach USD 59.8 Billion by 2030, Driven by Rising Pl …
The Dairy Alternatives Market is projected to be valued at USD 35.53 billion in 2025 and reach USD 59.8 billion by 2030, growing at a CAGR of 10.97% during the forecast period (2025-2030).
The global dairy alternatives market is experiencing remarkable growth, driven by increasing consumer preference for plant-based and lactose-free products. The shift towards veganism, concerns over lactose intolerance, and the growing awareness of the environmental impact of dairy farming…
Wind Turbine Market Projected to Reach 1.39 Thousand Gigawatts by 2030 Amidst Te …
Mordor Intelligence has published a new report on the Wind Turbine Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Wind Turbine Market is projected to grow from 0.21 thousand gigawatts in 2025 to 1.39 thousand gigawatts by 2030, with a compound annual growth rate (CAGR) of 45.66% during the forecast period (2025-2030). The growth of the wind turbine market is driven by the rising demand…
Saudi Arabia Renewable Energy Market to Reach 29.27 GW by 2030, Driven by Ambiti …
Mordor Intelligence has published a new report on the Saudi Arabia Renewable Energy Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Saudi Arabia Renewable Energy Market is projected to grow from 10.27 gigawatts in 2025 to 29.27 gigawatts by 2030, reflecting a compound annual growth rate (CAGR) of 23.3% during the forecast period (2025-2030).
Saudi Arabia's renewable energy sector is experiencing a significant transformation, fueled by…
Aluminum Market Projected to Surpass USD 150 Billion by 2030 Amidst Sustainabili …
Mordor Intelligence has published a new report on the Aluminum Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Aluminum Market is projected to grow at a CAGR of over 3.5% during the forecast period and expected to exceed USD 150 billion by 2030.
The aluminum industry is undergoing a major transformation, driven by sustainability initiatives and technological advancements. Leading manufacturers are placing greater emphasis on producing low-carbon…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
